vTv Therapeutics Inc.
VTVT
$20.99
-$1.75-7.70%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | 1.00M | 1.00M | 1.00M | -- | 9.00K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 1.00M | 1.00M | 1.00M | -- | 9.00K |
Cost of Revenue | 8.23M | 7.83M | 7.72M | 9.01M | 10.84M |
Gross Profit | -7.23M | -6.83M | -6.72M | -9.01M | -10.83M |
SG&A Expenses | 13.55M | 12.81M | 12.40M | 11.91M | 11.73M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 25.00M | 23.86M | 24.70M | 25.50M | 27.15M |
Operating Income | -24.00M | -22.86M | -23.70M | -25.50M | -27.14M |
Income Before Tax | -22.61M | -25.31M | -26.11M | -25.97M | -27.62M |
Income Tax Expenses | 100.00K | 100.00K | 100.00K | -- | 0.00 |
Earnings from Continuing Operations | -22.71 | -25.41 | -26.21 | -25.97 | -27.62 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 4.40M | 5.23M | 5.60M | 5.72M | 6.10M |
Net Income | -18.31M | -20.18M | -20.62M | -20.25M | -21.52M |
EBIT | -24.00M | -22.86M | -23.70M | -25.50M | -27.14M |
EBITDA | -23.91M | -22.77M | -23.61M | -25.41M | -27.05M |
EPS Basic | -7.63 | -8.99 | -9.55 | -9.71 | -10.37 |
Normalized Basic EPS | -4.05 | -4.72 | -4.97 | -5.58 | -5.74 |
EPS Diluted | -7.63 | -8.99 | -9.55 | -9.71 | -10.37 |
Normalized Diluted EPS | -4.05 | -4.72 | -4.97 | -5.58 | -5.74 |
Average Basic Shares Outstanding | 9.56M | 9.04M | 8.69M | 8.34M | 8.29M |
Average Diluted Shares Outstanding | 9.56M | 9.04M | 8.69M | 8.34M | 8.29M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |